Advanced Filters
noise

Human Growth Hormone Clinical Trials

A listing of Human Growth Hormone medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 317 clinical trials
A Anna Moyana, B.S.

Exercise for Memory Rehabilitation in Epilepsy

The purpose of this study is to determine how effective a 6-week exercise program is for improving memory compared to a no-intervention control group, investigate the brain changes that may be responsible for memory improvements, and determine if the memory benefits and brain changes are retained 6 weeks after completing …

18 - 55 years of age All Phase N/A
D Dongfang Li

Ketogenic Diet in Pediatric Intractable Epilepsy

This study aims to evaluate the efficacy of a ketogenic diet in treating pediatric intractable epilepsy and to explore its relationship with changes in inflammatory markers. The investigators plan to recruit 59 participants with intractable epilepsy, 39 of whom will receive a combination of ketogenic diet and conventional antiepileptic drugs, …

6 - 12 years of age All Phase N/A
L Liankun Ren, MD

Temporal Interference for Drug Resistant Epilepsy

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.

6 - 60 years of age All Phase N/A
C Cheng-Chia Lee, MD. PhD.

Focused Ultrasound for Drug-resistant Epilepsy

Focused ultrasound (FUS) has been shown to differentially lesion or modulate (excite and inhibit) brain circuit and neural activity across a broad range of acoustic stimulus parameters (intensity, duty cycle, pulse repetition frequency and pulse duration) for decades. From our previous study, FUS sonication may suppress the number of epileptic …

18 years of age All Phase N/A
D Daniel Goldenholz, MD PhD

Infrared Photobiomodulation in Humans With Epilepsy

Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to …

18 years of age All Phase N/A
C Colleen Stone

Sleep Architecture & Cognition in Focal Epilepsy

Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the …

18 - 40 years of age All Phase N/A

TIzanidine for the Preventive Treatment of Episodic MigrainE (TIME)

In this study,189 adult migraine patients aged 18-65 years (diagnosed with migraine without aura and/or migraine with aura, with at least a 1-year history)will be collected to evaluate the efficacy, safety and tolerability of Tizanidine Hydrochloride in preventing migraine attacks in episodic migraine in adults.

18 - 65 years of age All Phase 3
S Simple Futarmal Kothari

Trial Designs for Evaluating Migraine Treatment

The study aims to estimate treatment effects in randomized controlled trials (RCT) and a balanced placebo design (BPD) to specify how contextual and psychological factors interact in acute migraine treatment and influence adverse event occurrence. Using a clinical within-subjects design, patients with episodic migraine will receive six treatment conditions in …

18 - 65 years of age All Phase N/A
A Abdelrahim A Sadek, MD, PhD

Exogenous Ketone Esters for Drug Resistant Epilepsy

This study aims to investigate the efficacy of add-on exogenous ketone esters for treating children with drug-resistant epilepsy

1 - 16 years of age All Phase 2/3
E Eric H Kossoff, MD

Ketogenic Diet for New-Onset Absence Epilepsy

The ketogenic diet is a medical therapy for epilepsy that is used nearly predominantly for refractory epilepsy (after 2-3 drugs have been tried and failed). However, there is both published evidence for first-line use (infantile spasms, Glut1 deficiency syndrome) and also anecdotal experience (families choosing to change the child's (or …

3 - 12 years of age All Phase 3

Simplify language using AI